¥60.39 ($9.00)

+0.05 (+0.08%)

SHZ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 32 · ¥28.1B mcap · 284M float · 9.35% daily turnover

Revenue

$2.6B -19.8% ▼

5Y CAGR: +29.7%

Gross Profit

$1.8B -7.6% ▼

5Y CAGR: +59.7%

Operating Income

$2.1B +30.8% ▲

5Y CAGR: +152.5%

Net Income

$1.7B +33.3% ▲

5Y CAGR: +90.5%

EPS (Diluted)

$3.78 +36.5% ▲

5Y CAGR: +89.8%

EBITDA

$709M -14.4% ▼

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$2.0B	$2.4B	$26.3B	$3.2B	$2.6B
YoY Growth	+184.4%	+19.4%	+997.8%	-87.7%	-19.8%
Cost of Revenue	$907M	$885M	$5.5B	$1.3B	$785M
Gross Profit	$1.1B	$1.5B	$20.8B	$2.0B	$1.8B
Gross Margin	54.9%	63.1%	79.0%	60.5%	69.7%
R&D Expenses	$78M	$67M	$246M	$278M	$269M
SG&A Expenses	$581M	$493M	$2.0B	$861M	$856M
Operating Expenses	$863M	$510M	$2.5B	$343M	-$303M
Operating Income	$239M	$1.0B	$18.3B	$1.6B	$2.1B
Operating Margin	11.9%	41.8%	69.6%	49.9%	81.4%
Interest Expense	$10M	$17M	$7M	$15M	$69M
Income Before Tax	$240M	$1000M	$18.3B	$1.6B	$2.1B
Tax Expense	$3M	$65M	$1.8B	$231M	$307M
Net Income	$242M	$909M	$16.0B	$1.3B	$1.7B
Net Margin	12.1%	37.9%	60.9%	38.7%	64.4%
EPS (Diluted)	$0.56	$2.00	$34.30	$2.77	$3.78
EBITDA	$478M	$985M	$18.6B	$829M	$709M
Shares Outstanding	433M	455M	467M	452M	441M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$741M	$500M	$507M	$258M	$304M	$296M	$301M	$230M
Cost of Revenue	$183M	$192M	$150M	$120M	$111M	$124M	$93M	$77M
Gross Profit	$558M	$308M	$357M	$139M	$193M	$172M	$208M	$153M
Gross Margin	75.4%	61.5%	70.5%	53.7%	63.4%	58.2%	69.0%	66.4%
R&D Expenses	$59M	$91M	$88M	$80M	$58M	$100M	$52M	$61M
SG&A Expenses	$261M	$227M	$234M	$249M	$193M	$158M	$155M	$187M
Operating Expenses	-$416M	$15M	$54M	-$539M	$254M	-$768M	-$182M	-$3.0B
Operating Income	$975M	$292M	$304M	$678M	-$62M	$940M	$390M	$3.1B
Operating Margin	131.5%	58.4%	59.9%	262.3%	-20.2%	317.4%	129.3%	1365.0%
Interest Expense	$17M	$19M	$19M	$36M	$33M	$26M	$30M	$38M
Income Before Tax	$975M	$290M	$304M	$678M	$615M	$931M	$386M	$3.1B
Tax Expense	$142M	$23M	$26M	$35M	-$52M	$249M	$81M	$367M
Net Income	$767M	$300M	$266M	$654M	$669M	$678M	$294M	$2.8B
Net Margin	103.5%	60.0%	52.5%	253.2%	220.0%	228.7%	97.4%	1208.4%
EPS (Diluted)	$1.79	$0.68	$0.60	$1.50	$1.63	$1.57	$0.69	$6.63
EBITDA	$267M	-$13M	$39M	-$190M	$648M	-$71M	$7M	$3.2B
Shares Outstanding	429M	441M	444M	437M	410M	431M	428M	419M

002432.SZ SHZ